Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice
Shujuan Zhang, Dongfeng Wei, Shuang Lv, et al.
Journal of Alzheimer s Disease (2022) Vol. 89, Iss. 3, pp. 955-975
Closed Access | Times Cited: 21

Showing 21 citing articles:

Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review
Zhao Da, Kailin Yang, Hua Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114312-114312
Open Access | Times Cited: 46
Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access | Times Cited: 2
Jiao-tai-wan and its effective component-berberine improve diabetes and depressive disorder through the cAMP/PKA/CREB signaling pathway
Yueheng Tang, Yang Gao, Kexin Nie, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117829-117829
Open Access | Times Cited: 12
Scutellarin ameliorates mitochondrial dysfunction and apoptosis in OGD/R-insulted HT22 cells through mitophagy induction
Lu Yang, Xianfeng Liu, Siyin Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117340-117340
Open Access | Times Cited: 10
The potential of the gut microbiome for identifying Alzheimer’s disease diagnostic biomarkers and future therapies
Yu Zhan, Murad Al‐Nusaif, Cong Ding, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
Trilobatin suppresses aging-induced cognitive impairment by targeting SIRT2: Involvement of remodeling gut microbiota to mediate the brain-gut axis
Dianyou Xie, Lin Mu, Yun-mei Luo, et al.
Phytomedicine (2024) Vol. 130, pp. 155744-155744
Closed Access | Times Cited: 5
Gut Microbiota Modulation of Dementia Related Complications
Xiaoqing Su, Yinghua Chen, Xingxing Yuan
Aging and Disease (2025)
Open Access
Unlocking the neuroprotective secrets of natural products: a focus on the gut-brain axis
Xiliang Yang, Die Hu, R. Cheng, et al.
Phytochemistry Reviews (2025)
Closed Access
HDAC3 as an Emerging Therapeutic Target for Alzheimer's Disease and other Neurological Disorders
Yonghe Li, Taha Izhar, Takahisa Kanekiyo
Molecular Neurobiology (2025)
Closed Access
Targeting the gut–microbiota–brain axis in irritable bowel disease to improve cognitive function – recent knowledge and emerging therapeutic opportunities
He-yong Tang, Xiaoqi Chen, Shun Huang, et al.
Reviews in the Neurosciences (2023) Vol. 34, Iss. 7, pp. 763-773
Closed Access | Times Cited: 9
Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases
Shanshan Nie, Shan Zhang, Ruipeng Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Influence of the brain‑gut axis on neuroinflammation in cerebral ischemia‑reperfusion injury (Review)
Yifeng Zhang, Hang Yang, Shuai Hou, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 2
Dengzhan Shengmai Capsule Ameliorates Cognitive Impairment via Inhibiting ER stress in APP/PS1 Mice
Huihan Ma, Jiayi Zheng, Yuhui Qiu, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119016-119016
Closed Access | Times Cited: 2
Exploiting the beneficial effects of Salvia officinalis L. extracts in human health and assessing their activity as potent functional regulators of food microbiota
Vasiliki Kompoura, Ioanna Karapantzou, Gregoria Mitropoulou, et al.
Food Chemistry (2023) Vol. 441, pp. 138175-138175
Closed Access | Times Cited: 4
Erigeron breviscapus: A Promising Medication for Protecting the Optic Nerve in Glaucoma
Yuxin Cheng, Xuanyi Chen, Guangyu Zhu, et al.
Planta Medica (2024)
Closed Access | Times Cited: 1
Microbiota–gut–brain axis and related therapeutics in Alzheimer’s disease: prospects for multitherapy and inflammation control
Jiahao Li, Feng Zhang, Li Zhao, et al.
Reviews in the Neurosciences (2023) Vol. 34, Iss. 6, pp. 695-718
Closed Access | Times Cited: 3
Gut Microbiota Defined Epigenomes of Alzheimer’s and Parkinson’s Diseases Reveal Novel Targets for Therapy
Shabnam Nohesara, Hamid M. Abdolmaleky, Sam Thiagalingam, et al.
Epigenomics (2023) Vol. 16, Iss. 1, pp. 57-77
Closed Access | Times Cited: 3
Harnessing unexplored medicinal values of the red listed South African weed Erigeron bonariensis: From ethnobotany to biomedicine
Vishal Mahanur, Rahul R. Rajge, Rashmi Saxena Pal, et al.
South African Journal of Botany (2023) Vol. 160, pp. 535-546
Closed Access | Times Cited: 2
Advances in Anti-Diabetic Cognitive Dysfunction Effect of Erigeron Breviscapus (Vaniot) Hand-Mazz
Shanye Gu, Ziyi Zhou, Shijie Zhang, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 50-50
Open Access | Times Cited: 3
The role of gut microbiota in chronic restraint stress-induced cognitive deficits in mice
Qiong Ling, Junhong Zhang, Lin Zhong, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access
Research Progress in the Treatment of Alzheimer’s Disease Based on Microbiota-Gut-Brain Axis
蝶 张
Advances in Clinical Medicine (2023) Vol. 13, Iss. 12, pp. 20380-20385
Closed Access
Page 1

Scroll to top